Government commits $25m to medicine safety research

The federal Government will invest $25 million in research to improve the safe use of medicines and medicines intervention by pharmacists.

Cost of asthma treatment – a deterrent to use

Cost is a major factor associated with non-adherence to asthma treatment in Australia, recent research revealed. Healthcare providers can assist patients with adherence by...

NSW pharmacists given special authority to supply essential medicines

NSW has granted pharmacists a landmark special authority to supply most S4 medicines without a prescription to those affected by bushfires. The NSW Chief Health...

From the President: PSA at the FIP World Congress in Seville,...

I have just returned from FIP’s World Congress of Pharmacy and Pharmaceutical Sciences in Seville, where PSA CEO Mark Kinsela, PSA Senior Pharmacist Peter...

Pharmacists in 2023 – unlocking the future of pharmacy

A major new PSA report, Pharmacists in 2023, reveals a roadmap for the changes needed to ensure the profession’s potential is realised – and...

The importance of a multimodal approach to pain management

The shift from viewing pain as simply a symptom opens up opportunities to greatly improve the way it is treated, writes PainWISE MD Joyce...